Could a common spice change how drugs work in your body?
NCT ID NCT05157672
First seen Aug 24, 2026 · Last updated Aug 25, 2026 · Updated 1 time
Summary
This study looks at whether taking cinnamon supplements changes how the body handles certain medications. Healthy adults will take cinnamon along with nicotine gum and the breast cancer drug letrozole to see if cinnamon alters drug levels. The findings could help guide future research on cinnamon as a smoking cessation aid and on its impact for people taking letrozole.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- cinnamon dietary supplement (2 g oral capsules)
- What this could lead to
- If cinnamon changes how the body breaks down nicotine, it might one day support smoking cessation efforts. It could also inform safer use of letrozole in cancer patients.
- What could go wrong
- This is a very early, small study in healthy volunteers, so results may not apply to real-world patients. Cinnamon could also interact with other drugs in unexpected ways.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Early phase 1
The earliest testing in people: a first look at safety, in a very small group.
- Participants
-
16 people
The number who actually took part.
- Started
-
Dec 2021
- Finished
-
Aug 2024
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 64 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Males and females, aged from 18-64 years and healthy * Not taking any medications (prescription and non-prescription) or dietary/herbal supplements known to alter the pharmacokinetics of either study drug or cinnamon constituents * Willing to abstain from consuming dietary/herbal supplements and citrus juices for several weeks * Willing to abstain from consuming caffeinated beverages or other caffeine-containing products the evening before and morning of the first day of a study arm * Willing to abstain from consuming any alcoholic beverages for one day prior to any study day, during the 14-hour inpatient days, and for the outpatient visit(s) following the 14-hour visit * Willing to use an acceptable method of contraception that does not include oral contraceptive pills or patches (such as abstinence, copper IUD, condom) * Have the time to participate * Written informed consent (and assent when applicable) obtained from subject or subject's legal representative and ability for the subject to comply with the requirements of the study Exclusion Criteria: * Under the age of 18 or 65+ years * Any current major illness or chronic illness such as (but not limited to) kidney disease, hepatic disease, diabetes mellitus, hypertension, coronary artery disease, chronic obstructive pulmonary disease, cancer, or HIV/AIDS * History of anemia or any other significant hematologic disorder * History of drug or alcohol addiction or major psychiatric illness * Pregnant or nursing * History of allergy to cinnamon, letrozole, or nicotine * Taking concomitant medications, both prescription and non-prescription (including dietary supplements/herbal products), known to alter the pharmacokinetics of either study drug or cinnamon constituents * Presence of a condition or abnormality that, in the opinion of the Investigator, would compromise the safety of the patient or the quality of the data * Recreational drug use such as amphetamines, benzodiazepines, cocaine, marijuana, MDMA, opioids, and PCP * History of intolerance to cinnamon * Out-of-range clinical laboratory value that the study physician considers participation in the study a health risk
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Interaction drug food are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Washington State University College of Pharmacy and Pharmaceutical Sciences
Spokane, Washington, 99202, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.